I

Published

January 19, 2021

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

PICOID

ec8a39fc

DOI

10.1016/j.canrad.2020.12.003

Citations

Keywords

Carcinome hépatocellulaire, Chimioembolisation transartérielle, Curiethérapie endovasculaire, Endovascular brathytherapy, Hepatocellular carcinoma, I(125) irradiation stent, Meta-analysis, Méta-analyse, Portal vein tumor thrombus, Stent d’iode125, Thrombose tumorale de la veine porte, Transarterial chemoembolization

Patients/Population/Participants

patients

Intervention

TACE and I

Comparison

control group

Outcome

6-month, 12-month stent cumulative patency rate, 6-month, 12-month, 24-month overall survival rate, objective response rate of PVTT, main portal venous pressure changes, treatment-related adverse events

Abstract

A meta-analysis aimed to systematically evaluate the safety and efficiency of I The Cochrane library, PubMed/Medline, EMBASE, CNKI, Wanfang Data and CQVIP were systematically screened out from the earliest to December 2019. The qualities of all included studies were assessed. The primary endpoints were the 6-month, 12-month stent cumulative patency rate and 6-month, 12-month, 24-month overall survival rate while the secondary endpoints were the objective response rate of PVTT, main portal venous pressure changes and treatment-related adverse events. Our meta-analysis was conducted using Stata 12.0 software. Totally seven studies with 1018 patients were included in the final analysis, in which 602 patients received TACE and I I

I

Abstract

Similar article map